当前位置: 首页 >> 检索结果
共有 8575 条符合本次的查询结果, 用时 2.2678069 秒

301. Population Screening With Natriuretic Peptides Is Ready for Prime Time.

作者: Antoni Bayés-Genis.
来源: Circulation. 2025年151卷22期1547-1549页

302. TET2-Mutant Clonal Hematopoiesis Promotes Heart Failure With Preserved Ejection Fraction.

作者: Ambarish Pandey.;Toby Thomas.;Yuanyuan Ji.;Benjamin Kroger.;Peter Carlsgaard.;Camila I Irion.;Fatma Kalkan.;Matthew Segar.;Vinayak Subramanian.;Antoni Bayés-Genís.;Albert Son.;Kira A Young.;Jennifer J Trowbridge.;Naveen Premnath.;Nan Jiang.;Daniel Daou.;Wenhuo Hu.;Sarah A Ware.;Dan Tong.;Stephen S Chung.
来源: Circulation. 2025年151卷22期1622-1625页

303. Response by Maurizi et al to Letter Regarding Article, "Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry".

作者: Niccolò Maurizi.;Panagiotis Antiochos.;Sharlene M Day.;Iacopo Olivotto.
来源: Circulation. 2025年151卷22期e1045-e1046页

304. Impact of Initial Extensive Ablation on Left Atrial Gaps During Redo Procedures and Subsequent Outcomes in Persistent Atrial Fibrillation.

作者: Masato Okada.;Koichi Inoue.;Nobuaki Tanaka.;Masaharu Masuda.;Tetsuya Watanabe.;Nobuhiko Makino.;Yasuyuki Egami.;Takafumi Oka.;Hitoshi Minamiguchi.;Miwa Miyoshi.;Takashi Kanda.;Yasuhiro Matsuda.;Masato Kawasaki.;Koji Tanaka.;Yuko Hirao.;Shungo Hikoso.;Akihiro Sunaga.;Tomoharu Dohi.;Daisaku Nakatani.;Katsuki Okada.;Yohei Sotomi.;Yasushi Sakata.; .
来源: Circ Arrhythm Electrophysiol. 2025年18卷6期e013612页
The efficacy of extensive linear ablation strategies, in addition to pulmonary vein (PV) isolation, remains controversial in persistent atrial fibrillation (AF) ablation. Gaps in previously ablated lesions can induce arrhythmias and potentially decrease the effectiveness of extensive ablation. This study evaluated the incidence of conduction gaps, gap-related reentry, and subsequent recurrence following redo AF ablation in the EARNEST-PVI trial (Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation; REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03514693).

305. Evaluation of Bioprosthetic Valve Dysfunction in the SMART Randomized Clinical Trial.

作者: Howard C Herrmann.;Daniel J Blackman.;Guilherme F Attizzani.;Mohamed Abdel-Wahab.;Wayne B Batchelor.;Linda D Gillam.;Toby Rogers.;Jae K Oh.;Andrew D Althouse.;Roxana Mehran.;Didier Tchétché.
来源: Circ Cardiovasc Interv. 2025年18卷8期e015202页

306. Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review.

作者: Sara L Hungerford.;Kay Everett.;Edmund Lau.;Daniel Burkhoff.;Navin K Kapur.
来源: Circ Heart Fail. 2025年e012611页
The pulsatile nature of blood flow and the hydrostatic effect of pulmonary capillary wedge pressure are 2 fundamental, yet often overlooked features of right ventricular-pulmonary arterial interactions in advanced heart failure and cardiogenic shock. These 2 features (above all others) define both the mechanical forces experienced by the pulmonary arteries, and in turn, the vascular afterload imposed by the pulmonary circulation on the right ventricular. For over half a century, it has been assumed that the pulsatile components of the pulmonary circulation exist in predictable and constant proportion to resistive afterload. In other words, that the vascular afterload can be estimated from mean pulmonary arterial pressure and pulmonary vascular resistance alone. While this tenet holds true for most forms of pulmonary hypertension, pulmonary hypertension resulting from the passive transmission of elevated left atrial pressure is a notable exception. In these cases, arterial compliance decreases proportionally more than any increase in pulmonary vascular resistance and is highly dependent upon recruitment and distensibility of the pulmonary circulation. As questions regarding the optimal method to predict right ventricular failure resurface, along with a modern armamentarium of techniques to assess pulsatile pressure-flow relations, it serves as a timely reminder that, in those with normal or near-normal pulmonary arterial pressures, the pulsatile component of pulmonary vascular afterload may account for anywhere between one-quarter and half of the total power of the right ventricular. In this State-of-the-Art Review, we address the role of pulmonary circulation in those with advanced heart failure and cardiogenic shock. Unlike previous discussions on this topic, we set aside considerations of established precapillary disease, focusing specifically on the process by which an acute or chronic elevation of pulmonary capillary wedge pressure results in pulmonary hypertension from left-sided heart failure. In doing so, we create a framework to assess pulmonary vascular afterload in an era of advanced therapeutics and device technologies to treat advanced heart failure and cardiogenic shock.

307. Letter by Manuel Regarding Article, "Progressive LV Dysfunction and Adverse Outcomes After Aortic Valve Replacement With Bioprosthetic Valves in Young Patients".

作者: Valdano Manuel.
来源: Circ Cardiovasc Imaging. 2025年18卷7期e018428页

308. Unfolding Evidence on Risk Stratification in Women Using Quantitative Atherosclerotic Plaque Measurements.

作者: Leslee J Shaw.;Fay Y Lin.
来源: Circ Cardiovasc Imaging. 2025年18卷6期e018438页

309. Steal Phenomenon of Thoracic False Lumen: Imaging Insights From Postdissection Cases.

作者: Yangyang Ge.;Hongpeng Zhang.;Yeqing Qi.;Wei Guo.
来源: Circ Cardiovasc Imaging. 2025年18卷7期e018220页
Persistent thoracic false lumen flow and subsequent aortic expansion are common complications following thoracic endovascular aortic repair for type B aortic dissection, as well as aortic arch replacement with the elephant trunk technique for type A aortic dissection. Although thoracic false lumen-perfused branches are known to contribute to thoracic false lumen backflow, robust imaging evidence is still lacking. This review illustrates how these branches perpetuate thoracic false lumen flow through detailed imaging analysis, emphasizing the critical need for advancing rapid, accurate, and minimally invasive imaging techniques and novel therapeutic devices to address this persistent clinical challenge.

310. Prolonged Extreme Asymptomatic Hypertroponinemia as a Milestone in Diagnosis of Familial Arrhythmogenic Right Ventricular Cardiomyopathy.

作者: Sergej Prijic.;Ivana Cerovic.;Vladislav Vukomanovic.;Sasa Popovic.;Maja Popovic.;Sanja Ninic.;Stasa Krasic.;Marija Zdravkovic.
来源: Circ Heart Fail. 2025年18卷8期e012713页

311. Resuscitation Practices at Emergency Medical Service Agencies Working in Black and Hispanic Versus White Catchment Areas in the United States.

作者: Paul S Chan.;Saket Girotra.;Khadijah Breathett.;Kimberly C Dukes.;Jessica Sperling.;Christina M Pacheco.;Kevin F Kennedy.;Comilla Sasson.;Bryan McNally.;Heather Schacht Reisinger.;Marina Del Rios.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷6期e011799页
Although survival for out-of-hospital cardiac arrest (OHCA) is lower at emergency medical service (EMS) agencies serving Black/Hispanic communities, it is unknown whether this is due to practice differences.

312. Response to Letter Regarding Article, "Comparing the Efficacy of Sirolimus and Paclitaxel-Eluting Balloon Catheters in the Treatment of Coronary In-Stent Restenosis: A Prospective Randomized Study (TIS 2 Study)".

作者: Leos Pleva.;Pavel Kukla.;Tomas Kovarnik.;Jana Zapletalova.
来源: Circ Cardiovasc Interv. 2025年18卷7期e015470页

313. Letter by Movahed Regarding Article, "Chronic Total Occlusion Percutaneous Coronary Intervention: Present and Future".

作者: Mohammad Reza Movahed.
来源: Circ Cardiovasc Interv. 2025年18卷7期e015552页

314. Aspirin in Dual Antiplatelet Therapy After PCI: One Duration Does Not Fit All.

作者: Uwe Zeymer.;Christoph B Olivier.;Daniel Dürschmied.
来源: Circ Cardiovasc Interv. 2025年18卷7期e015518页

315. Cardiovascular Epidemiology: From Findings to Impact.

作者: Khadijah Breathett.;Emily C O'Brien.;Norrina Allen.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷6期e012347页

316. Validation of ICD-10 Codes to Distinguish Between Claudication and Chronic Limb-Threatening Ischemia in Patients Undergoing Peripheral Vascular Intervention Using Medicare-Matched Registry Data.

作者: Sanuja Bose.;David P Stonko.;Sharon C Kiang.;Daniel Roh.;Jialin Mao.;Andrew Cabrera.;Chen Dun.;Philip P Goodney.;James H Black.;Leigh Ann O'Banion.;Jesse A Columbo.;Roger T Tomihama.;Caitlin W Hicks.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷7期e011467页
The accuracy of contemporary administrative claims codes to discriminate between different phenotypes of peripheral artery disease is not well defined. We aimed to validate a predefined set of International Classification of Diseases, Tenth Revision, codes used to distinguish between claudication and chronic limb-threatening ischemia (CLTI) and to optimize their diagnostic accuracy using a supervised machine-learning approach.

317. Building a Sustainable Cardiac Surgery Program in Sub-Saharan Africa: The Case of Angola.

作者: Valdano Manuel.;Jeffrey P Jacobs.;Frank Edwin.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷7期e012261页

318. Living in Rural America Plants the Seeds for Congenital Heart Disease Challenges.

作者: J Carter Ralphe.;Petros V Anagnostopoulos.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷6期e012231页

319. Forgotten After Discharge? ECMO Patients Deserve Better.

作者: Shan P Modi.;Manreet K Kanwar.
来源: Circ Heart Fail. 2025年18卷6期e013176页

320. Myocardial Perfusion PET-CT: There's More Here Than Meets the (A)I.

作者: Matthew James Memmott.;Andrew Michael Crean.;Parthiban Arumugam.
来源: Circ Cardiovasc Imaging. 2025年18卷7期e018488页
共有 8575 条符合本次的查询结果, 用时 2.2678069 秒